Actually DG.......this topic of AZD0046 into clinical trials has not been talked about seriously.......that I can remember
When the CEO states confidently in interviews (2 in fact) about early 2018 CY......AZD0046 will go into clinical trials, and then draws it out to sometime in 2018.....and then stops talking about when it will happen.......one needs to ask the question as to why......is it due to AstraZeneca putting foot on brake......because in the way Jackie has used adjectives to describe results from pre-clinical of AZD0046 and give asssurance of time lines........one needs to wonder if anything has changed
Are AstraZeneca preparing to purchase spl, page-57
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
